![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 304.38 | MF: C12H21N2O3PS |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
100 mg
|
severe
|
CIGET* -,-,1977
|
skin | rabbit
500 mg open irritation test
|
moderate
|
CIGET* -,-,1977
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
lung
|
100 mg/L/27 hour
|
MUREAV 66,277,1979
|
cytogenetic analysis
|
human
lymphocyte
|
500 µg/L
|
TSITAQ 18,1490,1976
|
DNA damage
|
intraperitoneal | mouse
8.12 mg/kg/1 day
|
TOXID9 78,426,2004
|
DNA inhibition
|
multiple | other fish
640 µg/L
|
STEVA8 76,63,1988
|
micronucleus test
|
hamster
ovary
|
52.7 mg/L/24 hour (-enzymatic activation step)
|
MUREAV 582,116,2005
|
micronucleus test
|
hamster
ovary
|
94 mg/L/3 hour (+enzymatic activation step)
|
MUREAV 582,116,2005
|
micronucleus test
|
human
lymphocyte
|
4 mg/L
|
MUREAV 388,27,1997
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
60 mg/L
|
EMMUEG 12,85,1988
|
morphological transform
|
rat
embryo
|
11 µg/plate
|
JJATDK 1,190,1981
|
other mutation test systems
|
human
lymphocyte
|
500 µg/L
|
BIHAA2 38(Pt1),344,1971
|
other mutation test systems
|
multiple | other fish
1,060 µg/L
|
STEVA8 76,63,1988
|
sister chromatid exchange
|
multiple | other fish
540 pmol/L
|
MUREAV 118,61,1983
|
sister chromatid exchange
|
rat
lymphocyte
|
20 mg/L/2 hour
|
MUREAV 472,85,2000
|
sperm morphology
|
human
sperm
|
50 µmol/L/1 hour
|
REPTED 22,508,2006
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 8.12 mg/kg (1 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Other effects on male
TOXID9 78,426,2004
|
intraperitoneal | rat
lowest published toxic dose: 100 mg/kg (11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
AEHLAU 16,805,1968
|
intraperitoneal | rat
lowest published toxic dose: 150 mg/kg (11 day pregnant)
|
Reproductive: Other effects on female | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
AEHLAU 16,805,1968
|
intraperitoneal | rat
lowest published toxic dose: 200 mg/kg (11 day pregnant)
|
Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
AEHLAU 16,805,1968
|
oral | mouse
lowest published toxic dose: 3,960 µg/kg (1-22 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on newborn: Behavioral Reproductive: Effects on newborn: Delayed effects
JTEHD6 3,989,1977
|
oral | mouse
lowest published toxic dose: 189 mg/kg (1-21 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
JEPTDQ 2(2),357,1978
|
oral | mouse
lowest published toxic dose: 3,780 µg/kg (1-21 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
JEPTDQ 2(2),357,1978
|
oral | mouse
lowest published toxic dose: 210 µg/kg (1-21 day pregnant)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system | Reproductive: Effects on newborn: Delayed effects
JEPTDQ 4(5-6),53,1980
|
oral | mouse
lowest published toxic dose: 189 mg/kg (1-21 day pregnant)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
|
JEPTDQ 4(5-6),53,1980
|
oral | pig
lowest published toxic dose: 570 mg/kg (1-16 week pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
32OAAP -,253,1973
|
oral | rat
lowest published toxic dose: 26,400 µg/kg (12-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
JFMAAQ 54,452,1967
|
oral | rat
lowest published toxic dose: 45 mg/kg (8-12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
JFMAAQ 54,452,1967
|
oral | rat
lowest published toxic dose: 63,500 µg/kg (10 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
JFMAAQ 54,452,1967
|
oral | rabbit
lowest published toxic dose: 130 mg/kg (6-18 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
NNGADV 14,113,1989
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | guinea pig
lethal concentration (50 percent kill): 5,500 mg/m3/4 hour
|
N/R
|
PSDTAP 15,239,1974
|
inhalation | mouse
lethal concentration (50 percent kill): 1,600 mg/m3/4 hour
|
N/R
|
PSDTAP 15,239,1974
|
inhalation | rat
lethal concentration (50 percent kill): 3.5 gm/m3/4 hour
|
N/R
|
ENTOX* -,785,2005
|
intramuscular | monkey
lowest published toxic dose: 10 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
JOPSEQ 19,455,2005
|
intramuscular | monkey
lowest published toxic dose: 90 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JOPSEQ 19,455,2005
|
intramuscular | monkey
lowest published toxic dose: 130 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Tremor Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JOPSEQ 19,455,2005
|
intraperitoneal | mouse
lethal dose (50 percent kill): 33 mg/kg
|
N/R
|
TXAPA9 2,495,1960
|
intraperitoneal | mouse
lowest published toxic dose: 30 mg/kg
|
Brain and Coverings: Other degenerative changes
|
TOLED5 135,89,2002
|
intraperitoneal | mouse
lowest published toxic dose: 8.12 mg/kg
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
TXAPA9 202,189,2005
|
intraperitoneal | mouse
lowest published toxic dose: 30 mg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
TXAPA9 205,149,2005
|
intraperitoneal | mouse
lowest published toxic dose: 30 mg/kg
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
TXAPA9 224,98,2007
|
intraperitoneal | rat
lethal dose (50 percent kill): 65 mg/kg
|
N/R
|
ARZNAD 5,436,1955
|
intraperitoneal | rat
lowest published toxic dose: 6.5 mg/kg
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOLED5 170,229,2007
|
intraperitoneal | rat
lowest published toxic dose: 65 mg/kg
|
Brain and Coverings: Other degenerative changes
|
TOLED5 170,229,2007
|
intratracheal | rat
lethal dose (50 percent kill): 210 mg/kg
|
N/R
|
JJATDK 19,133,1999
|
intravenous | mouse
lethal dose (50 percent kill): 180 mg/kg
|
N/R
|
CSLNX* NX#00023
|
oral | domestic bird
lowest published toxic dose: 0.5 mg/kg
|
Behavioral: Analgesia
|
TOXID9 90,322,2006
|
oral | wild bird
lethal dose (50 percent kill): 2 mg/kg
|
N/R
|
TXAPA9 21,315,1972
|
oral | chicken
lethal dose (50 percent kill): 8,400 µg/kg
|
N/R
|
85DPAN -,-,1971/1976
|
oral | duck
lethal dose (50 percent kill): 3,500 µg/kg
|
N/R
|
DOEAAH 35,25,1979
|
oral | guinea pig
lethal dose (50 percent kill): 250 mg/kg
|
N/R
|
85DPAN -,-,1971/1976
|
oral | human
lowest published toxic dose: 214 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Muscle weakness Skin and Appendages: Other: Sweating
CTOXAO 12,435,1978
|
oral | mouse
lethal dose (50 percent kill): 17 mg/kg
|
N/R
|
SKEZAP 24,268,1983
|
oral | pigeon
lethal dose (50 percent kill): 3,160 µg/kg
|
N/R
|
ASTTA8 (680),157,1979
|
oral | pig
lethal dose (50 percent kill): 320 mg/kg
|
N/R
|
YKYUA6 31,459,1980
|
oral | quail
lethal dose (50 percent kill): 4,210 µg/kg
|
N/R
|
ASTTA8 (680),157,1979
|
oral | rat
lethal dose (50 percent kill): 66 mg/kg
|
N/R
|
DOEAAH 35,25,1979
|
oral | rat
lowest published toxic dose: 1 mg/kg
|
Brain and Coverings: Other degenerative changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 72,306,2003
|
oral | rat
lowest published toxic dose: 100 mg/kg
|
Eye: Lacrimation | Behavioral: Change in motor activity (specific assay) Gastrointestinal: Changes in structure or function of salivary glands
TOXID9 1,112,2001
|
oral | rat
lowest published toxic dose: 15 mg/kg
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 205,31,2005
|
oral | rat
lowest published toxic dose: 30 mg/kg
|
Brain and Coverings: Other degenerative changes
|
TXAPA9 205,31,2005
|
oral | rat
lowest published toxic dose: 6 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TOSCF2 92,235,2006
|
oral | rat
lowest published toxic dose: 60 mg/kg
|
Behavioral: Ataxia | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOSCF2 92,235,2006
|
oral | rabbit
lethal dose (50 percent kill): 143 mg/kg
|
N/R
|
YKYUA6 31,459,1980
|
subcutaneous | mouse
lethal dose (50 percent kill): 58 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Reactivates cholinesterase
|
OIZAAV 71,6099,1959
|
skin | mouse
lethal dose (50 percent kill): 2,750 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
JTEHD6 9,491,1982
|
skin | pig
lethal dose (50 percent kill): 633 mg/kg
|
N/R
|
YKYUA6 31,459,1980
|
skin | rat
lethal dose (50 percent kill): 180 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
PMJMAQ -,155,1957
|
skin | rabbit
lethal dose (50 percent kill): 3.6 gm/kg
|
N/R
|
ENTOX* -,785,2005
|
unreported route | mammal (species unspecified)
lethal dose (50 percent kill): 76 mg/kg
|
N/R
|
30ZDA9 -,338,1971
|
unreported route | rat
lethal dose (50 percent kill): 250 mg/kg
|
N/R
|
RISHDJ 23,101,1983
|
unreported route | rat
lowest published toxic dose: 75 mg/kg
|
Brain and Coverings: Other degenerative changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TOXID9 66,312,2002
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 201 µg/m3/24 hour/13 week- continuous
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
GISAAA 42(1),6,1977
|
intraperitoneal | mouse
lowest published toxic dose: 40 mg/kg/28 day- intermittent
|
Blood: Other changes | Immunological Including Allergic: Decreased immune response Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TXCYAC 196,173,2004
|
intraperitoneal | mouse
lowest published toxic dose: 500 mg/kg/28 day- intermittent
|
Blood: Changes in spleen | Immunological Including Allergic: Decreased immune response Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
TXCYAC 196,173,2004
|
oral | dog
lowest published toxic dose: 4,900 mg/kg/35 week- intermittent
|
Gastrointestinal: Other changes | Blood: Changes in erythrocyte (RBC) count Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXAPA9 18,285,1971
|
oral | dog
lowest published toxic dose: 1,200 mg/kg/46 week- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JAFCAU 3,1017,1955
|
oral | dog
lowest published toxic dose: 157 mg/kg/12 week- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
|
TXAPA9 1,1,1959
|
oral | dog
lowest published toxic dose: 3,395 mg/kg/1 year- continuous
|
Brain and Coverings: Other degenerative changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NNGADV 14,113,1989
|
oral | domestic animal
lowest published toxic dose: 1,050 mg/kg/21 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
|
VHTODE 41,287,1999
|
oral | mouse
lowest published toxic dose: 26,280 mg/kg/2 year- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
NNGADV 14,113,1989
|
oral | mouse
lowest published toxic dose: 1,620 mg/kg/45 day- continuous
|
Blood: Changes in spleen | Blood: Other changes Immunological Including Allergic: Uncharacterized (multiple organ involvement)
TXCYAC 172,13,2002
|
oral | mouse
lowest published toxic dose: 1.62 gm/kg/45 day- intermittent
|
Blood: Hemorrhage | Blood: Changes in spleen Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXCYAC 172,13,2002
|
oral | mouse
lowest published toxic dose: 750 mg/kg/15 day- intermittent
|
Immunological Including Allergic: Decrease in cellular immune response
|
TXCYAC 236,123,2007
|
oral | pig
lowest published toxic dose: 2,450 mg/kg/35 week- intermittent
|
Gastrointestinal: Other changes | Blood: Changes in erythrocyte (RBC) count Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 18,285,1971
|
oral | rat
lowest published toxic dose: 46 mg/kg/92 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
AECTCV 9,637,1980
|
oral | rat
lowest published toxic dose: 86 mg/kg/30 day- continuous
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
TXAPA9 54,359,1980
|
oral | rat
lowest published toxic dose: 91 mg/kg/26 week- continuous
|
Blood: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
JPFCD2 16,1,1981
|
oral | rat
lowest published toxic dose: 371 mg/kg/14 day- continuous
|
Blood: Change in clotting factors
|
JEPOEC 7(3),67,1987
|
oral | rat
lowest published toxic dose: 28 mg/kg/28 week- intermittent
|
Liver: Fatty liver degeneration | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
BECTA6 37,501,1986
|
oral | rat
lowest published toxic dose: 1,095 mg/kg/2 year- continuous
|
Endocrine: Changes in thyroid weight | Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NNGADV 14,113,1989
|
oral | rat
lowest published toxic dose: 98 mg/kg/28 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites
DCTODJ 9,117,1986
|
oral | rat
lowest published toxic dose: 70 mg/kg/1 week- intermittent
|
Liver: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport
TXCYAC 211,197,2005
|
oral | rat
lowest published toxic dose: 280 mg/kg/4 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
ETOPFR 22,46,2006
|
oral | rat
lowest published toxic dose: 70 mg/kg/1 week- intermittent
|
Blood: Thrombocytopenia | Blood: Changes in erythrocyte (RBC) count Blood: Changes in leukocyte (WBC) count
ETOPFR 22,46,2006
|
oral | rat
lowest published toxic dose: 70 mg/kg/1 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases
|
ETOPFR 22,46,2006
|
oral | rat
lowest published toxic dose: 50 mg/kg/5 day- intermittent
|
Gastrointestinal: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TOLED5 161,200,2006
|
skin | rabbit
lowest published toxic dose: 210 mg/kg/21 day- intermittent
|
Blood: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
NNGADV 14,113,1989
|
unreported route | rat
lowest published toxic dose: 2 mg/kg/4 day- intermittent
|
Cardiac: Other changes | Endocrine: Differential effect of sex or castration on observed toxicity Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOXID9 -,271,2008
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.01 mg/m3 (inhalable, vapor, skin)
|
DTLVS* TLV/BEI,2007
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not classifiable as human carcinogen
|
DTLVS* TLV/BEI,2007
|
TOXICOLOGY REVIEW
|
|
AQMOAC #73-19,1973
|
TOXICOLOGY REVIEW
|
|
RREVAH 46,1,1973
|
TOXICOLOGY REVIEW
|
|
CNDQA8 10(3),43,1975
|
TOXICOLOGY REVIEW
|
|
DTTIAF 80,485,1973
|
TOXICOLOGY REVIEW
|
|
RREVAH 63,1,1976
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,29,2002
|
TOXICOLOGY REVIEW
|
|
TOLED5 142,207,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 589,208,2005
|
TOXICOLOGY REVIEW
|
|
MUTAEX 21,93,2006
|
TOXICOLOGY REVIEW
|
|
NETOX* 26,531,2005
|
TOXICOLOGY REVIEW
|
|
NETOX* 26,573,2005
|
TOXICOLOGY REVIEW
|
|
CCATAR 366,1,2006
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,588,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,785,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,306,2005
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,308,2005
|
TOXICOLOGY REVIEW
|
|
JTCTDW 42,579,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 584,1,2005
|
TOXICOLOGY REVIEW
|
|
JTEHD6 7,267,2004
|
TOXICOLOGY REVIEW
|
|
REPTED 23,260,2007
|
TOXICOLOGY REVIEW
|
|
FEREAC 73,29456,2008
|
TOXICOLOGY REVIEW
|
|
REPTED 26,1,2008
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Supported
|
RBREV* -,109,1998
|
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.1 mg/m3 (skin)
|
DTLVS* 3,780,1971
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.1 mg/m3, JUL2008
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.01 mg/m3 (vapor, aerosol), Skin, MAR2002
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.1 mg/m3, OCT 2002
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.1 mg/m3, short term exposure limit 0.3 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.1 mg/m3, Skin, FEB2006
|
Occupational Exposure Limit - GERMANY
|
MAK 0.1 mg/m3 (inhalable), 2005
|
Occupational Exposure Limit - HUNGARY
|
time-weighted average 0.1 mg/m3, short term exposure limit 0.4 mg/m3, Skin, SEP2000
|
Occupational Exposure Limit - INDIA
|
time-weighted average 0.1 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 0.1 mg/m3, skin, APR2007
|
Occupational Exposure Limit - KOREA
|
time-weighted average 0.1 mg/m3, skin, 2006
|
Occupational Exposure Limit - MEXICO
|
time-weighted average 0.1 mg/m3; | short term exposure limit 0.3 mg/m3 (skin), 2004
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.1 mg/m3, 2003
|
Occupational Exposure Limit - NEW ZEALAND
|
time-weighted average 0.1 mg/m3, skin, JAN2002
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.1 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 0.2 mg/m3, JUN2003
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.1 mg/m3,KZG- week 0.2 mg/m3, Skin, DEC2006
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not classifiable as human carcinogen
Occupational Exposure Limit IN SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not classifiable as human carcinogen | ||||||||||||||||||||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO DIAZINON-air
|
10 hour time-weighted average 0.1 mg/m3 (Sk)
|
NIOSH* DHHS #95-121,1995
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 23360; | Number of Industries 9; Total Number of Facilities 1,268; Number of Occupations 9; Total Number of Employees Exposed 26,581
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 23360 |
Number of Industries 10; Total Number of Facilities 3,168; Number of Occupations 18; Total Number of Employees Exposed 39,342; Total Number of Female Employees Exposed 3,216 | ||||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/97/121107/AS)
|
EPA GENETOX PROGRAM 1988, Negative: Carcinogenicity-mouse/rat; Histidine reversion-Ames test
|
EPA GENETOX PROGRAM 1988, Negative: In vitro UDS-human fibroblast; TRP reversion
|
EPA GENETOX PROGRAM 1988, Negative: S cerevisiae-homozygosis
|
EPA GENETOX PROGRAM 1988, Inconclusive: B subtilis rec assay; E coli polA without S9
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as an agricultural chemical and pesticide
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: Organophosphorus pesticides, 5600
|
NCI Carcinogenesis Bioassay (feed);no evidence:mouse,rat
|
NCITR* NCI-TR-137,1979
|
OSHA ANALYTICAL METHOD #ID-62
|
| |||||||||||||
REFERENCES:
CODEN
|
|
REFERENCE
30ZDA9
|
"Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971
|
32OAAP
|
"Pesticide and the Environment: a Continuing Controversy, Selected Papers Presented and Papers
Reviewed at the 8th Inter-American Conference on Toxicology and Occupational Medicine, Miami,
FL, 1973," Deichmann, W.B., ed., New York, Stratton Intercontinental Medical Book Corp., 1973
|
85DPAN
|
"Wirksubstanzen der Pflanzenschutz und Schadlingsbekampfungsmittel," Perkow, W., Berlin,
Verlag Paul Parey, 1971-1976
|
AECTCV
|
Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
|
AEHLAU
|
Archives of Environmental Health. (Heldref Pub., 4000 Albemarle St., NW, Washington, DC
20016) V.1- 1960-
|
AQMOAC
|
Air Quality Monographs. (Washington, DC) No.69-1 - No.75-25, 1969-75(?). Discontinued.
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
ASTTA8
|
ASTM Special Technical Publication. (American Soc. for Testing Materials, 1916 Race St.,
Philadelphia, PA 19103) No.1- 1911-
|
BECTA6
|
Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
|
BIHAA2
|
Bibliotheca Haematologica (Basel). (S. Karger AG, Postfach, CH-4009 Basel, Switzerland) No.1-
1955-
|
CCATAR
|
Clinica Chimica Acta. (Elsevier Science B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1956-
|
CIGET*
|
Ciba-Geigy Toxicology Data/Indexes. (Ciba-Geigy Corp., 556 Morris Ave., Summit, NJ 07901)
|
CNDQA8
|
Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris,
France) V.1- 1966-
|
CSLNX*
|
U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange
Chemicals. (Aberdeen Proving Ground, MD 21010)
|
CTOXAO
|
Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW.
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DOEAAH
|
Down to Earth. (Dow Chemical USA, Agricultural Products Dept., Midland, MI 48640) V.1-
1945-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
DTTIAF
|
Deutsche Tieraerztliche Wochenschrift. (Hanover, Fed. Rep. Ger.) V.1-77, 1893-1970.
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENTOX*
|
Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
|
ETOPFR
|
Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA
19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1-
Feb.1996-
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
JAFCAU
|
Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office
Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953-
|
JEPOEC
|
Journal of Environmental Pathology, Toxicology and Oncology. (Chem-Orbital, POB 134, Park
Forest, IL 60466) V.5(4)- 1984-
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JFMAAQ
|
Journal of the Florida Medical Association. (Florida Medical Assoc., POB 2411, Jacksonville,
FL 32203) V.1- 1914-
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JOPSEQ
|
Journal of Psychopharmacology (Oxford). (Oxford University Press, Great Clarendon St., Oxford
OX2 6DP, UK) V.1- 1987-
|
JPFCD2
|
Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and
Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976-
|
JTCTDW
|
Journal of Toxicology, Clinical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY
10016) V.19- 1982-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NETOX*
|
NeuroToxicology (Amsterdam : Elsevier Science) V.1- 1979-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NNGADV
|
Nippon Noyaku Gakkaishi. Journal of the Pesticide Science Society of Japan. (Nippon Noyaku
Gakkai, 1-43-11, Komagome, Toshima-ku, Tokyo 170, Japan) V.1- 1976-
|
OIZAAV
|
Osaka Igaku Zasshi. (Osaka, Japan)
|
PMJMAQ
|
Proceedings of the Annual Meeting of the New Jersey Mosquito Extermination Association. (New
Brunswick, NJ) V.1-61, 1914-74.
|
PSDTAP
|
Proceedings of the European Society for the Study of Drug Toxicity. (Princeton, NJ 08540)
V.1-15, 1963-74. For publisher information, see PESTD5.
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
RISHDJ
|
Rinsho Shinkeigaku. Clinical Neurology. (Societas Neurologica Japonica, Ichi-Maru Bldg.
31-21 Yushima 2-Chome, Bunkyo-ku 113 Tokyo, Japan) V.1- 1960-
|
RREVAH
|
Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
07094) V.1- 1962-
|
SKEZAP
|
Shokuhin Eiseigaku Zasshi. Food Hygiene Journal. (Nippon Shokuhin Eisei Gakkai c/o Shokuhin
Eisei Senta, 2-6-1 Jingumae, Shibuya-ku, Tokyo 150, Japan) V.1- 1960-
|
STEVA8
|
Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1972-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TSITAQ
|
Tsitologiya. Cytology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1959-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VHTODE
|
Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology,
Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
|
YKYUA6
|
Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950-
|
| |